BENITEC BIOPHARMA LTD's ticker is BNTCW and the CUSIP is 082053117. A total of 2 filers reported holding BENITEC BIOPHARMA LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -50.0% | 50,000 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $4,000 | +300.0% | 50,000 | 0.0% | 0.01% | +200.0% |
| Q3 2019 | $1,000 | -66.7% | 50,000 | -66.7% | 0.00% | +100.0% |
| Q2 2019 | $3,000 | -50.0% | 150,000 | +200.0% | 0.00% | -83.3% |
| Q1 2019 | $6,000 | 0.0% | 50,000 | 0.0% | 0.01% | -53.8% |
| Q4 2018 | $6,000 | 0.0% | 50,000 | 0.0% | 0.01% | +30.0% |
| Q3 2018 | $6,000 | 0.0% | 50,000 | 0.0% | 0.01% | +42.9% |
| Q2 2018 | $6,000 | -50.0% | 50,000 | 0.0% | 0.01% | -56.2% |
| Q1 2018 | $12,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 90,193 | $32,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 50,000 | $18,000 | 0.00% |
| UBS Group AG | 385 | $0 | 0.00% |